Variant report

Variant	esv3340257
Chromosome Location	chr2:179057106-179061404
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:553)
CpG islands
(count:611)
Chromatin interactive
region (count:16)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:553 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:179059192-179059308	K562	blood:	n/a	n/a
2	ARID3A	chr2:179058147-179058700	HepG2	liver:	n/a	n/a
3	BACH1	chr2:179058869-179058966	K562	blood:	n/a	n/a
4	BACH1	chr2:179059663-179060261	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr2:179058627-179059213	H1-hESC	embryonic stem cell:	n/a	n/a
6	BHLHE40	chr2:179059725-179060345	K562	blood:	n/a	n/a
7	BHLHE40	chr2:179058252-179058609	HepG2	liver:	n/a	n/a
8	BHLHE40	chr2:179058398-179059517	K562	blood:	n/a	n/a
9	BRCA1	chr2:179060038-179060272	Hela-S3	cervix:	n/a	n/a
10	CBX3	chr2:179059841-179060241	K562	blood:	n/a	n/a
11	CBX3	chr2:179058754-179059585	K562	blood:	n/a	n/a
12	CCNT2	chr2:179058576-179060455	K562	blood:	n/a	n/a
13	CEBPB	chr2:179059697-179060389	IMR90	lung:	n/a	n/a
14	CEBPB	chr2:179058072-179059362	Hela-S3	cervix:	n/a	n/a
15	CEBPB	chr2:179059704-179059973	K562	blood:	n/a	n/a
16	CEBPB	chr2:179058054-179058776	HepG2	liver:	n/a	n/a
17	CEBPB	chr2:179058152-179058608	HepG2	liver:	n/a	n/a
18	CEBPB	chr2:179058137-179058562	HepG2	liver:	n/a	n/a
19	CEBPB	chr2:179058249-179058417	HepG2	liver:	n/a	n/a
20	CEBPB	chr2:179060223-179060508	K562	blood:	n/a	n/a
21	CEBPB	chr2:179059649-179060530	Hela-S3	cervix:	n/a	n/a
22	CEBPB	chr2:179058190-179058515	A549	lung:	n/a	n/a
23	CEBPB	chr2:179058590-179058717	H1-hESC	embryonic stem cell:	n/a	n/a
24	CEBPB	chr2:179059757-179060042	H1-hESC	embryonic stem cell:	n/a	n/a
25	CEBPD	chr2:179058191-179058490	HepG2	liver:	n/a	n/a
26	CEBPD	chr2:179058214-179058617	HepG2	liver:	n/a	n/a
27	CHD1	chr2:179058524-179059060	H1-hESC	embryonic stem cell:	n/a	n/a
28	CHD1	chr2:179059290-179059478	H1-hESC	embryonic stem cell:	n/a	n/a
29	CHD2	chr2:179059013-179059142	H1-hESC	embryonic stem cell:	n/a	n/a
30	CHD2	chr2:179058920-179060350	K562	blood:	n/a	n/a
31	CHD2	chr2:179059684-179060277	H1-hESC	embryonic stem cell:	n/a	n/a
32	CHD2	chr2:179059419-179059815	HepG2	liver:	n/a	n/a
33	CHD2	chr2:179058389-179060267	Hela-S3	cervix:	n/a	n/a
34	CHD2	chr2:179058320-179058460	HepG2	liver:	n/a	n/a
35	CHD2	chr2:179058533-179058768	H1-hESC	embryonic stem cell:	n/a	n/a
36	CREB1	chr2:179058444-179058852	H1-hESC	embryonic stem cell:	n/a	n/a
37	CREB1	chr2:179058042-179058792	HepG2	liver:	n/a	n/a
38	CREB1	chr2:179058443-179058928	H1-hESC	embryonic stem cell:	n/a	n/a
39	CREB1	chr2:179058442-179059535	K562	blood:	n/a	n/a
40	CREB1	chr2:179058808-179059341	A549	lung:	n/a	n/a
41	CTBP2	chr2:179058381-179060303	H1-hESC	embryonic stem cell:	n/a	n/a
42	CTCF	chr2:179059140-179059290	HUVEC	blood vessel:	n/a	n/a
43	CTCF	chr2:179059040-179059190	GM12864	blood:	n/a	chr2:179059040-179059053
44	CTCF	chr2:179059780-179059930	GM06990	blood:	n/a	n/a
45	CTCF	chr2:179058943-179059440	H1-hESC	embryonic stem cell:	n/a	chr2:179059040-179059053
46	CTCF	chr2:179059860-179060010	HCM	heart:	n/a	chr2:179059980-179059993
47	CTCF	chr2:179059940-179060090	AG09319	gingival:	n/a	chr2:179059980-179059993
48	CTCF	chr2:179059160-179059310	HFF	foreskin:	n/a	n/a
49	CTCF	chr2:179059143-179059297	LNCaP	prostate:	n/a	n/a
50	CTCF	chr2:179059220-179059370	GM12870	blood:	n/a	n/a

(count:611 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:179059440-179059490	NH-A	brain:	n/a
2	chr2:179059440-179059490	NH-A	brain:	n/a
3	chr2:179060117-179060167	MCF-7	breast:	n/a
4	chr2:179059440-179059490	BJ	skin:	n/a
5	chr2:179061183-179061233	HEK293	kidney:	embryo
6	chr2:179060117-179060167	HMEC	breast:	n/a
7	chr2:179058698-179058748	U87	brain:	n/a
8	chr2:179061183-179061233	NHBE	bronchial:	n/a
9	chr2:179060011-179060061	HMEC	breast:	n/a
10	chr2:179059452-179059502	GM19239	blood:	n/a
11	chr2:179058025-179058075	NH-A	brain:	n/a
12	chr2:179059440-179059490	HRPEpiC	eye:	n/a
13	chr2:179061183-179061233	NHDF-neo	bronchial:	n/a
14	chr2:179058698-179058748	BE2_C	brain:	n/a
15	chr2:179058025-179058075	K562	blood:	n/a
16	chr2:179059440-179059490	HCF	heart:	n/a
17	chr2:179058157-179058207	HMEC	breast:	n/a
18	chr2:179060011-179060061	HCPEpiC	choroid plexus:	n/a
19	chr2:179060117-179060167	NHBE	bronchial:	n/a
20	chr2:179058025-179058075	ECC-1	luminal epithelium:	n/a
21	chr2:179058157-179058207	HRCEpiC	kidney:	n/a
22	chr2:179058612-179058662	NHBE	bronchial:	n/a
23	chr2:179058157-179058207	HUVEC	blood vessel:	n/a
24	chr2:179060011-179060061	HRPEpiC	eye:	n/a
25	chr2:179060117-179060167	GM12891	blood:	n/a
26	chr2:179059440-179059490	SK-N-SH	brain:	n/a
27	chr2:179059452-179059502	NHBE	bronchial:	n/a
28	chr2:179058612-179058662	GM06990	blood:	n/a
29	chr2:179061183-179061233	HMEC	breast:	n/a
30	chr2:179058698-179058748	HepG2	liver:	n/a
31	chr2:179060117-179060167	GM06990	blood:	n/a
32	chr2:179059452-179059502	NB4	blood:	n/a
33	chr2:179059440-179059490	Hela-S3	cervix:	n/a
34	chr2:179060117-179060167	GM12878	blood:	n/a
35	chr2:179060011-179060061	HCT-116	colon:	n/a
36	chr2:179060011-179060061	A549	lung:	n/a
37	chr2:179058612-179058662	SK-N-SH	brain:	n/a
38	chr2:179058157-179058207	MCF10A-Er-Src	breast:	n/a
39	chr2:179058698-179058748	PrEC	prostate:	n/a
40	chr2:179060011-179060061	MCF10A-Er-Src	breast:	n/a
41	chr2:179058612-179058662	Hepatocyte	liver:	n/a
42	chr2:179059452-179059502	HL-60	blood:	n/a
43	chr2:179059452-179059502	GM12891	blood:	n/a
44	chr2:179059452-179059502	NH-A	brain:	n/a
45	chr2:179058698-179058748	NHBE	bronchial:	n/a
46	chr2:179058025-179058075	MCF-7	breast:	n/a
47	chr2:179060117-179060167	HL-60	blood:	n/a
48	chr2:179060117-179060167	H1-hESC	embryonic stem cell:	embryo
49	chr2:179058157-179058207	Hela-S3	cervix:	n/a
50	chr2:179059452-179059502	HNPCEpiC	eye:	n/a

(count:16 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:178978462..178980467-chr2:179057158..179058664,2	MCF-7	breast:
2	chr2:179054368..179057331-chr2:179057745..179062443,7	K562	blood:
3	chr2:179059539..179061742-chr2:179114111..179116745,2	K562	blood:
4	chr2:179060830..179065562-chr2:179066300..179070960,4	K562	blood:
5	chr2:179060480..179062055-chr2:179072193..179074054,2	K562	blood:
6	chr2:179054368..179057331-chr2:179058369..179060505,5	K562	blood:
7	chr2:178976797..178977610-chr2:179058506..179059074,2	MCF-7	breast:
8	chr2:179057756..179060082-chr2:179314891..179318046,3	MCF-7	breast:
9	chr2:179061327..179064018-chr2:179074389..179076022,2	K562	blood:
10	chr2:179056933..179060923-chr2:179315358..179318702,4	MCF-7	breast:
11	chr2:178976327..178979048-chr2:179055214..179057976,2	K562	blood:
12	chr2:178975761..178978600-chr2:179056476..179059620,3	K562	blood:
13	chr2:178975067..178978289-chr2:179058254..179060575,4	MCF-7	breast:
14	chr2:178979115..178980922-chr2:179059390..179062250,2	K562	blood:
15	chr2:178940431..178942693-chr2:179060357..179062621,2	K562	blood:
16	chr2:178937601..178939157-chr2:179060683..179062611,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RBM45-9	chr2:179059216-179059401	NONHSAT075739

No data

Variant related genes	Relation type
OSBPL6	TF binding region
OSBPL6	CpG island
ENSG00000155636	chromatin interactions
ENSG00000204311	chromatin interactions
ENSG00000079156	chromatin interactions
ENSG00000180228	chromatin interactions

Extended variants
information (count: 154 )
Associated
traits (count: 57 )

Variant overlapped rSNPs/rCNVs (count:154 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs540936304	chr2:179057110-179057111	Weak transcription Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
2	rs369573242	chr2:179057151-179057152	Weak transcription Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs377690523	chr2:179057196-179057197	Weak transcription Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs190869289	chr2:179057232-179057233	Weak transcription Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
5	rs34547057	chr2:179057254-179057255	Weak transcription Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs184069365	chr2:179057262-179057263	Weak transcription Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs546249057	chr2:179057325-179057326	Weak transcription Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs371270250	chr2:179057404-179057405	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs549161644	chr2:179057411-179057412	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs111763079	chr2:179057418-179057419	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs372153999	chr2:179057443-179057444	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs528645548	chr2:179057447-179057448	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs552127623	chr2:179057448-179057449	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs59667571	chr2:179057451-179057452	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs200693472	chr2:179057452-179057453	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs71837668	chr2:179057453-179057454	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs35139829	chr2:179057467-179057468	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs115264873	chr2:179057472-179057473	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs549791817	chr2:179057507-179057508	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs569694167	chr2:179057596-179057597	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs188647632	chr2:179057619-179057620	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs375219942	chr2:179057653-179057654	Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs334123	chr2:179057671-179057672	Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs372532476	chr2:179057698-179057699	Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs557657280	chr2:179057707-179057708	Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs577507282	chr2:179057708-179057709	Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs376743800	chr2:179057756-179057757	Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs113331687	chr2:179057760-179057761	Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs192961513	chr2:179057811-179057812	Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs543126428	chr2:179057857-179057858	Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
31	rs545220539	chr2:179057866-179057867	Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
32	rs368767	chr2:179057919-179057920	Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs528726534	chr2:179057955-179057956	Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs183216013	chr2:179057982-179057983	Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
35	rs565616241	chr2:179057983-179057984	Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
36	rs531225017	chr2:179058040-179058041	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
37	rs550942973	chr2:179058078-179058079	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
38	rs562316605	chr2:179058099-179058100	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
39	rs569643180	chr2:179058126-179058127	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
40	rs528847863	chr2:179058140-179058141	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
41	rs568597193	chr2:179058235-179058236	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
42	rs537715265	chr2:179058270-179058271	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
43	rs16866154	chr2:179058362-179058363	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs334124	chr2:179058415-179058416	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs116572358	chr2:179058460-179058461	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs143407652	chr2:179058477-179058478	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs72964057	chr2:179058505-179058506	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs571064217	chr2:179058545-179058546	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
49	rs117807540	chr2:179058559-179058560	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
50	rs556945300	chr2:179058566-179058567	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:57)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Lung cancer	18438408	CNVD
Glioblastoma	21080181	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Prostate cancer	18632612	CNVD
Sudden cardiac death	19188705	CNVD
Acute myeloid leukemia	20729466	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Schizophrenia	18923514	CNVD
Schizophrenia	22241247	CNVD
Mental retardation	21062444	CNVD
Facial dysmorphism	20548289	CNVD
Mental retardation	20548289	CNVD
Schizophrenia	19348701	CNVD
Muscular dystrophy	17160897	CNVD
Cardiomyopathy	17576883	CNVD
Pancreatic cancer	17952125	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Bipolar disorder	19114987	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:534 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:179052600-179057800	Weak transcription	Pancreatic Islets	Pancreatic Islet
2	chr2:179055800-179058000	Enhancers	Liver	Liver
3	chr2:179056400-179058400	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
4	chr2:179056600-179058000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
5	chr2:179056600-179058000	Weak transcription	NHEK	skin
6	chr2:179056800-179058000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
7	chr2:179056800-179058000	Weak transcription	HMEC	breast
8	chr2:179057800-179058000	Enhancers	Adipose Nuclei	Adipose
9	chr2:179057800-179058000	Enhancers	Pancreatic Islets	Pancreatic Islet
10	chr2:179057800-179058000	Enhancers	Skeletal Muscle Male	skeletal muscle
11	chr2:179057800-179058000	Enhancers	Skeletal Muscle Female	skeletal muscle
12	chr2:179057800-179058000	Enhancers	Stomach Smooth Muscle	stomach
13	chr2:179057800-179058400	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
14	chr2:179058000-179058200	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
15	chr2:179058000-179058200	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
16	chr2:179058000-179058200	Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
17	chr2:179058000-179058200	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
18	chr2:179058000-179058200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
19	chr2:179058000-179058200	Enhancers	Breast Myoepithelial Primary Cells	Breast
20	chr2:179058000-179058200	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
21	chr2:179058000-179058200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
22	chr2:179058000-179058200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
23	chr2:179058000-179058200	Enhancers	Muscle Satellite Cultured Cells	--
24	chr2:179058000-179058200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
25	chr2:179058000-179058200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
26	chr2:179058000-179058200	Enhancers	Brain Anterior Caudate	brain
27	chr2:179058000-179058200	Enhancers	Brain Cingulate Gyrus	brain
28	chr2:179058000-179058200	Enhancers	Brain Inferior Temporal Lobe	brain
29	chr2:179058000-179058200	Enhancers	Brain Substantia Nigra	brain
30	chr2:179058000-179058200	Bivalent Enhancer	Fetal Intestine Large	intestine
31	chr2:179058000-179058200	Flanking Active TSS	Pancreatic Islets	Pancreatic Islet
32	chr2:179058000-179058200	Bivalent Enhancer	Fetal Stomach	stomach
33	chr2:179058000-179058200	Bivalent Enhancer	Small Intestine	intestine
34	chr2:179058000-179058200	Enhancers	Hela-S3	cervix
35	chr2:179058000-179058200	Enhancers	HMEC	breast
36	chr2:179058000-179058200	Enhancers	HSMMtube	muscle
37	chr2:179058000-179058200	Enhancers	NH-A	brain
38	chr2:179058000-179058200	Enhancers	NHDF-Ad	bronchial
39	chr2:179058000-179058200	Enhancers	Osteobl	bone
40	chr2:179058000-179058400	Flanking Bivalent TSS/Enh	H9 Derived Neuron Cultured Cells	ES cell derived
41	chr2:179058000-179058400	Flanking Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
42	chr2:179058000-179058400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
43	chr2:179058000-179058400	Bivalent/Poised TSS	Fetal Lung	lung
44	chr2:179058000-179058400	Bivalent Enhancer	Rectal Mucosa Donor 31	rectum
45	chr2:179058000-179058400	Flanking Bivalent TSS/Enh	A549	lung
46	chr2:179058000-179058600	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
47	chr2:179058000-179058600	Enhancers	Fetal Brain Male	brain
48	chr2:179058000-179058600	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
49	chr2:179058000-179058600	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
50	chr2:179058000-179058800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links